Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Treatment of Chronic Bacterial Prostatitis Caused by Enterococcus Faecalis

Introduction to Treatment

  • Linezolid 600 mg orally every 12 hours for 2-6 weeks is the recommended treatment for chronic bacterial prostatitis caused by Enterococcus faecalis, with expected success rates of 80-86% depending on treatment duration 1

Treatment Regimen and Duration

  • Linezolid 600 mg orally every 12 hours is strongly recommended as the backbone of therapy for E. faecalis chronic prostatitis, particularly for resistant strains 2, 1
  • For optimal outcomes, a treatment duration of 2-6 weeks is typically required, with longer durations associated with higher success rates 1
  • Pulse therapy approach can be considered: 2 weeks of linezolid followed by a 1-week rest period to minimize adverse effects such as myelosuppression 2
  • Initial symptom improvement typically occurs within 5-7 days, with more complete clinical response in 10-14 days 1

Success Rates Based on Duration

  • 2-week treatment course: Approximately 70-75% success rate 1
  • 4-week treatment course: Approximately 75-80% success rate 1
  • 6-week treatment course: Approximately 80-86% success rate (highest efficacy) 1
  • Multiple cycles may be needed for complete resolution in difficult cases 2

Monitoring and Adverse Effects

  • Weekly complete blood count monitoring is essential during prolonged therapy (>2 weeks) due to risk of myelosuppression 1
  • Watch for peripheral neuropathy and serotonin syndrome, especially with longer treatment durations 1
  • Drug interactions with serotonergic medications should be carefully assessed 1

Alternative Approaches

  • For vancomycin-resistant E. faecalis strains, linezolid remains particularly effective 2, 1
  • High-dose daptomycin (8-12 mg/kg/day) can be considered as an alternative if linezolid cannot be tolerated, though it may have less prostatic penetration 2, 1
  • Fluoroquinolones should be avoided due to high resistance rates (46-47%) unless susceptibility is confirmed 1

Special Considerations

  • Chronic bacterial prostatitis is difficult to treat due to limited antibiotic penetration into prostatic tissue and increasing antimicrobial resistance 2
  • E. faecalis is among the common pathogens in chronic bacterial prostatitis, alongside other organisms 3, 4

Common Pitfalls

  • Inadequate treatment duration is a common cause of failure - ensure full course completion 1
  • Lack of monitoring for adverse effects during extended therapy can lead to complications 1